As in the previous study, significantly higher antitumor activity was observed for ER-472 in the NRP1 WT versus KO model, while ER-271 was equipotent regardless of NRP1 status, with tumor regression observed in both models (Fig. 5b). This evidence concerns the gene NRP1 and neoplasm.